CD34 and myeloid neoplasm: On the other hand, most megakaryocytes in the normal/reactive BM usually are CD34-negative, so that a clear-cut expression of CD34 in a majority of megakaryocytes must be regarded as phenotypic aberrancy supporting the conclusion the patient suffers from a myeloid neoplasm such as MDS.